Physiologically Speaking

FEBRUARY 7, 2024

The consumption of ultraprocessed foods is increasing worldwide, and damning evidence implicates these “foods” in the diseases of civilization — type 2 diabetes, obesity, and cardiovascular disease. There’s no denying it — diet quality worldwide has declined dramatically in the last few decades. .”

Diet 98

Diet Public Health Obesity Diabetes 98

Circulation

JUNE 4, 2024

to 26.8%) and obesity (43.1% The prevalences of poor diet, inadequate physical activity, and smoking are estimated to improve over time, whereas inadequate sleep will worsen. Clinical and public health interventions are needed to effectively manage, stem, and even reverse these adverse trends. in 2020 to 61.0%

Risk Factors 81

Risk Factors Cardiovascular Disease Strokes Stroke 81

ADN Center of Excellence

SEPTEMBER 2, 2024

The Growing Global Burden of AFib The global incidence of AFib is on the rise, making it a significant public health concern. Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase.

AFIB 59

AFIB Atrial Fibrillation Innovation Heart Rhythm 59

ADN Center of Excellence

SEPTEMBER 2, 2024

The Growing Global Burden of AFib The global incidence of AFib is on the rise, making it a significant public health concern. Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase.

AFIB 52

AFIB Atrial Fibrillation Innovation Heart Rhythm 52

Cardiometabolic Health Congress

SEPTEMBER 29, 2023

Cardiometabolic Health Congress faculty member, Fátima Rodriguez, MD, MPH, has committed much of her clinical and research efforts to reducing health disparities in Hispanic-American communities. Cardiometabolic conditions – specifically obesity, diabetes and heart disease – disproportionately affect the 60 million people in the U.S.

Health Disparities 52

Health Disparities Obesity Heart Disease Cardiovascular Disease 52

DAIC

MARCH 8, 2024

Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.

Obesity 111

Obesity Heart Disease Heart Attack Heart attacks 111

Dr. Malcolm Kendrick

OCTOBER 30, 2024

At one point George Mann attempted to arrange a meeting of scientists who agreed that the diet-heart/cholesterol hypothesis was bunk. I believe you are right, and that the diet-heart hypothesis is wrong, but I cannot join you, for that would jeopardize my perks and funding. Just to choose a few paragraphs. ‘

Cholesterol 145

Cholesterol Article Research Diet 145